Salveen Richter
Stock Analyst at Goldman Sachs
(3.35)
# 1,029
Out of 5,124 analysts
206
Total ratings
41.74%
Success rate
5.42%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | Maintains: Neutral | $40 → $25 | $27.47 | -8.99% | 10 | Nov 20, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $9 → $11 | $14.28 | -22.97% | 3 | Nov 5, 2025 | |
| QURE uniQure | Maintains: Neutral | $56 → $38 | $22.31 | +70.33% | 9 | Nov 4, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $14 → $16 | $21.69 | -26.23% | 4 | Oct 30, 2025 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $45 → $65 | $81.49 | -20.24% | 5 | Sep 26, 2025 | |
| APLS Apellis Pharmaceuticals | Downgrades: Sell | $26 → $18 | $23.94 | -24.81% | 9 | Sep 26, 2025 | |
| IMNM Immunome | Initiates: Buy | $26 | $19.75 | +31.65% | 1 | Sep 22, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $504 → $566 | $406.40 | +39.27% | 6 | Sep 16, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $44 → $38 | $7.19 | +428.51% | 6 | Aug 12, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Neutral | $10 → $19 | $22.35 | -14.99% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $15 → $17 | $26.94 | -36.90% | 9 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $15.14 | +144.39% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $47 | $58.19 | -19.23% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $124 → $104 | $60.07 | +73.13% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $41 | $18.66 | +119.72% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $16.11 | -37.93% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $776.54 | +3.54% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $182.61 | +7.88% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $8.17 | +120.32% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $121.36 | -20.90% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $35.66 | +43.02% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $17.21 | +132.42% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $9.73 | +23.33% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $82 → $72 | $130.12 | -44.67% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $106.66 | -34.37% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $22.54 | +237.18% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $330.17 | +6.01% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $468.38 | +19.35% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $22.68 | -77.95% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.41 | +2,098.58% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $293.17 | -23.25% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $3.70 | +494.59% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $25.73 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.21 | +612.59% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $4.55 | +97.80% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $5.26 | -42.97% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $4.36 | +37.61% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $80.26 | -46.42% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $4.40 | -54.55% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $14.57 | +586.34% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $18.46 | +3,150.27% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $117.08 | -57.29% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $70.81 | -36.45% | 1 | Mar 17, 2020 |
Agios Pharmaceuticals
Nov 20, 2025
Maintains: Neutral
Price Target: $40 → $25
Current: $27.47
Upside: -8.99%
Amicus Therapeutics
Nov 5, 2025
Maintains: Neutral
Price Target: $9 → $11
Current: $14.28
Upside: -22.97%
uniQure
Nov 4, 2025
Maintains: Neutral
Price Target: $56 → $38
Current: $22.31
Upside: +70.33%
Arcus Biosciences
Oct 30, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $21.69
Upside: -26.23%
Ionis Pharmaceuticals
Sep 26, 2025
Upgrades: Neutral
Price Target: $45 → $65
Current: $81.49
Upside: -20.24%
Apellis Pharmaceuticals
Sep 26, 2025
Downgrades: Sell
Price Target: $26 → $18
Current: $23.94
Upside: -24.81%
Immunome
Sep 22, 2025
Initiates: Buy
Price Target: $26
Current: $19.75
Upside: +31.65%
Alnylam Pharmaceuticals
Sep 16, 2025
Maintains: Buy
Price Target: $504 → $566
Current: $406.40
Upside: +39.27%
4D Molecular Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $7.19
Upside: +428.51%
Sarepta Therapeutics
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $22.35
Upside: -14.99%
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $26.94
Upside: -36.90%
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $15.14
Upside: +144.39%
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $58.19
Upside: -19.23%
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $60.07
Upside: +73.13%
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $18.66
Upside: +119.72%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $16.11
Upside: -37.93%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $776.54
Upside: +3.54%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $182.61
Upside: +7.88%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $8.17
Upside: +120.32%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $121.36
Upside: -20.90%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $35.66
Upside: +43.02%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $17.21
Upside: +132.42%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $9.73
Upside: +23.33%
Jan 13, 2025
Maintains: Neutral
Price Target: $82 → $72
Current: $130.12
Upside: -44.67%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $106.66
Upside: -34.37%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $22.54
Upside: +237.18%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $330.17
Upside: +6.01%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $468.38
Upside: +19.35%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $22.68
Upside: -77.95%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.41
Upside: +2,098.58%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $293.17
Upside: -23.25%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $3.70
Upside: +494.59%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $25.73
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.21
Upside: +612.59%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $4.55
Upside: +97.80%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $5.26
Upside: -42.97%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $4.36
Upside: +37.61%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $80.26
Upside: -46.42%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $4.40
Upside: -54.55%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $14.57
Upside: +586.34%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $18.46
Upside: +3,150.27%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $117.08
Upside: -57.29%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $70.81
Upside: -36.45%